Ourania Tatsis, EVP, Chief Reg. & Quality Officer at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 6,484 shares at $499.99 ($3.2M) on 2025-03-10, disclosed to the SEC on 2025-03-12.
Scheduled sale ($3.2M) by EVP, Chief Reg. & Quality Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $499.99 | 3,242 | $1.6M | 50.0% |
| 2 | $499.99 | 3,242 | $1.6M | 50.0% |
| Total | $499.99 avg | 6,484 | $3.2M | 100% |
| Filing → |
| VRTX | SELL | 2026-02-19 | $472K | — | Filing → |
| VRTX | SELL | 2026-02-18 | $750K | — | Filing → |
| VRTX | SELL | 2026-02-12 | $215K | — | Filing → |